Page 2 - அமோய் பரிசோதனை இணை லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அமோய் பரிசோதனை இணை லிமிடெட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அமோய் பரிசோதனை இணை லிமிடெட் Today - Breaking & Trending Today

BRAF Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Share:
New York, April 09, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report BRAF Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) - https://www.reportlinker.com/p05948850/?utm source=GNW
The model discusses in detail the impact of COVID-19 on BRAF Tests market for the year 2020 and beyond. Melanoma is accounted for as the nineteenth most basic malignant growth around the world, with assessed age-standardized frequency rates of 2.8-3.1 per 100,000 . There is significant variety in frequency between nations, with the most high rates seen in Australia (37 for every 100,000) and the least in South-Central Asia (0.2 per 100,000). This pattern is ascribed to varieties in racial skin phenotype, just as contrasts in sun exposure around the globe.The fundamental environmental factor causing cutaneous melanoma is UV radiation. ....

United States , United Kingdom , Czech Republic , New Zealand , World Health Organization , Al Qahirah , South Korea , New York , South Africa , United Arab Emirates , Saudi Arabia , South Central Asia , Roche Ltd , Thermo Fisher Scientific Inc , Illumina Inc , Abbott Laboratories , Amoy Diagnostics Co Ltd , Vitro Diagnostics , Market Analysis , Forecast Model , World Health , Market Access , Key Opinion , Market Model , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் ,

ALK Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Share:
New York, April 09, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report ALK Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) - https://www.reportlinker.com/p05948847/?utm source=GNW
The model discusses in detail the impact of COVID-19 on ALK Tests market for the year 2020 and beyond.Globally, lung cancer is the second most common cancer in men and the third most common cancer in women.
Secondary sources estimate that approximately 2.0 million new cases of lung cancer were reported worldwide in 2018. Cigarette smoking is the dominant risk factor associated with lung cancer across all age groups, with approximately 80% of male and 45% of female lung cancer cases worldwide attributed to smoking. ....

United States , United Kingdom , Czech Republic , New Zealand , South Korea , New York , South Africa , United Arab Emirates , Saudi Arabia , Zytovision Gmb , Leica Biosystems Nussloch Gmb , Agilent Technologies Inc , Cytocell Ltd , Panagene Inc , Biocare Medical , Takara Bio Inc , Roche Diagnostics International Ltd , Thermo Fisher Scientific Inc , Amoy Diagnostics Co Ltd , Abbott Laboratories , Vitro Diagnostics , Market Analysis , Forecast Model , Market Access , Key Opinion , Zytovision Gmbh ,

Molecular Diagnostics Market worth $31.8 billion by 2026 - Exclusive Report by MarketsandMarkets

Molecular Diagnostics Market worth $31.8 billion by 2026 - Exclusive Report by MarketsandMarkets
Molecular Diagnostics Market
by Product & Service(Reagents, Kits, PoC & Tabletop Instruments), Application(COVID-19, Hepatitis, HAI, HIV, Oncology, Genetic Tests), Technology (PCR, NGS, ISH), End User (Hospitals, Diagnostic Labs) - Global Forecast to 2026 , published by MarketsandMarkets, the global market is projected to reach USD 31.8 billion by 2026 from USD 17.8 billion in 2021, at a 12.3% CAGR.
Browse in-depth TOC on
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=833
The increasing prevalence of infectious diseases and cancer, the rising funding for R&D, the increase in PoC testing devices and technological advancements drives growth in the molecular diagnostics market. Emerging economies such as China and Japan are providing lucrative opportunities for the players operating in the market. ....

United States , Kostenloser Wertpapierhandel , Asia Pacific , Aashish Mehra , Technology Immunoassay , Agilent Technologies Inc , Product Service Assays , Genmark Diagnostics Inc , Devices Market Research Reports Consulting , Quidel Corporation , Savyon Diagnostics Ltd , Diagnostics Ltd , Product Service Reagents , Mdxhealth Inc , Hologic Inc , Genetics Inc , End User Physician Office , Product Service Instrument , Research Insight , Illumina Inc , Thermo Fisher Scientific Inc , Amoy Diagnostics Co Ltd , Roche Ltd Switzerland , Luminex Corporation , Sciences Corporation , Molecular Diagnostics Inc ,

Global Cancer Genomic Cancer Panel and Profiling (Germline/Somatic) Markets to 2025: Factors Driving Growth - Level of Care, Companion Dx, Immuno-oncology, Liability, Aging Population

3.3.2 Bioinformatics Plays a Role
3.4 Diagnostic Technology Development
3.4.2 Single Cell Genomics Changes the Picture
3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment
3.4.4 CGES Testing, A Brave New World
3.4.5 Biochips/Giant magnetoresistance based assay
4. Cancer Panels & Profiles Recent Developments
4.1 Recent Developments - Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section
Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform
Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test
Metastatic Cancer Markers Identified in Clinical WGS Study
Stitch Bio Bets on CRISPR Tech
Bayer, LifeLabs Launch Free NTRK Genetic Testing Program
Foundation Medicine Liquid Biopsy Gets FDA Approval for Multiple Companion Dx ....

United States , Miltenyi Biotec , Yourgene Elucigene , Siemens Healthineers , Qiagen Gmbh , Sysmex Inostics , Laura Wood , Academic Research Lab , Testing Lab , Public National , Central Lab , Technology Development , Singlera Genomics Inc , Invitae Corporation , Physician Office Lab , Enzo Life Sciences Inc , Office Hours Call , Biodesix Inc , Datar Cancer Genetics , Fluidigm Corp , Accuragen Inc , Business Development Staff , Genefirst Ltd , Bioneer Corporation , Genomics Co , Thermo Fisher Scientific Inc ,

Global Cancer Genomic Cancer Panel and Profiling (Germline/Somatic) Markets to 2025: Factors Driving Growth - Level of Care, Companion Dx, Immuno-oncology, Liability, Aging Population

Global Cancer Genomic Cancer Panel and Profiling (Germline/Somatic) Markets to 2025: Factors Driving Growth - Level of Care, Companion Dx, Immuno-oncology, Liability, Aging Population
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Perkin Elmer , Miltenyi Biotec , Yourgene Elucigene , Siemens Healthineers , Qiagen Gmbh , Sysmex Inostics , Laura Wood , Academic Research Lab , Testing Lab , Public National , Central Lab , Technology Development , Singlera Genomics Inc , Invitae Corporation , Physician Office Lab , Enzo Life Sciences Inc , Office Hours Call , Biodesix Inc , Datar Cancer Genetics , Fluidigm Corp , Accuragen Inc , Business Development Staff , Genefirst Ltd , Bioneer Corporation , Genomics Co ,